Unseen Biometrics ApS - CVR: 40046585

2022, DKK

15.06.2023

Bruttoresultat

-1.811'

Primær drift

-3.753'

Årets resultat

-4.009'

Aktiver

6.475'

Kortfristede aktiver

2.675'

Egenkapital

381'

Afkastningsgrad

-58 %

Soliditetsgrad

6 %

Likviditetsgrad

111 %

Resultat

15.06.2023

Årsrapport	2022 15.06.2023	2021 28.06.2022	2020 09.07.2021	2018 20.07.2020
Nettoomsætning
Bruttoresultat	-1.810.793	-318.168	1.179.581	-14.457
Resultat af primær drift	-3.752.875	-942.821	1.179.581	0
Indtægter af kapitalandele (tilknyttede og associerede)	0	0	0	0
Finansielle indtægter	26	0	0	0
Finansieringsomkostninger	-256.092	-4.318	-100	0
Andre finansielle omkostninger	0	0	0	0
Resultat før skat	-4.008.941	-947.139	1.179.481	-14.457
Resultat	-4.008.941	-681.049	990.793	-13.643
Forslag til udbytte	0	0	0	0

Aktiver

15.06.2023

Årsrapport	2022 15.06.2023	2021 28.06.2022	2020 09.07.2021	2018 20.07.2020
Kortfristede varebeholdninger	158.278	0	0	0
Kortfristede tilgodehavender fra salg og tjenesteydelser	1.519.660	335.710	614.177	43.115
Likvider	996.960	73.822	693.744	51.821
Kortfristede aktiver	2.674.898	409.532	1.307.921	94.936
Immaterielle aktiver og goodwill	3.729.823	0	0	0
Finansielle anlægsaktiver	70.775	0	0	0
Materielle aktiver	0	0	0	0
Langfristede aktiver	3.800.598	2.117.765	1.242.867	163.639
Aktiver	6.475.496	2.527.297	2.550.788	258.575

Aktiver

15.06.2023

Passiver

15.06.2023

Årsrapport	2022 15.06.2023	2021 28.06.2022	2020 09.07.2021	2018 20.07.2020
Forslag til udbytte	0	0	0	0
Egenkapital	381.241	1.186.101	1.867.150	126.357
Hensatte forpligtelser	553.734	192.502	266.037	30.047
Langfristet gæld til banker	0	0	0	0
Anden langfristet gæld	0	0	0	0
Leverandører af varer og tjenesteydelser	331.338	66.840	130.495	1.250
Kortfristede forpligtelser	2.406.815	1.148.694	417.601	102.171
Gældsforpligtelser	5.540.521	1.148.694	417.601	102.171
Forpligtelser	5.540.521	1.148.694	417.601	102.171
Passiver	6.475.496	2.527.297	2.550.788	258.575

Passiver

15.06.2023

Nøgletal

15.06.2023

Årsrapport	2022 15.06.2023	2021 28.06.2022	2020 09.07.2021	2018 20.07.2020
Afkastningsgrad	-58,0 %	-37,3 %	46,2 %	Na.
Dækningsgrad	Na.	Na.	Na.	Na.
Resultatgrad	Na.	Na.	Na.	Na.
Varelagerets omsætningshastighed	Na.	Na.	Na.	Na.
Egenkapitals-forretning	-1.051,6 %	-57,4 %	53,1 %	-10,8 %
Payout-ratio	Na.	Na.	Na.	Na.
Gældsdæknings-nøgletal	-1.465,4 %	-21.834,7 %	1.179.581,0 %	Na.
Soliditestgrad	5,9 %	46,9 %	73,2 %	48,9 %
Likviditetsgrad	111,1 %	35,7 %	313,2 %	92,9 %

Resultat

15.06.2023

Gæld

15.06.2023

Årsrapport

15.06.2023

Nyeste:01.04.2022- 31.03.2023(offentliggjort: 15.06.2023)

Information om virksomhedens regnskabsklasse:The annual report of Unseen Biometrics ApS for 2021/22 has been prepared in accordance with the provisions applying to reporting class B entities under the Danish Financial Statements Act with opt-in from higher reporting classes.

Oplysning om pantsætninger og sikkerhedsstillelser:4. Charges and security For bank loans, DKK 3 million, the company has provided security in company assets representing a nominal value of DKK 5 million. This security comprises the assets below, stating the carrying amounts: DKK in thousands Inventories 158 Trade receivables 1.131 Plant and machinery 0 Other fixtures, fittings, tools and equipment 0 Intangible assets 3.730

Beretning

15.06.2023

Dato for ledelsens godkendelse af årsrapporten:2023-05-16

Statement by Management on the annual report

Identifikation af den godkendte årsrapport:Today, the Board of Directors and the Executive Board have approved the annual report of Unseen Biometrics ApS for the financial year 2022/23.

Management's review

Beskrivelse af virksomhedens væsentligste aktiviteter:Description of key activities of the company Like previous years, the activities are to operate as a commercial Biotech company within the field of Next Generation Microbiome Analysis. Uncertainties relating to going concern In order for the company to fulfill its obligations as they fall due and to ensure its continued operation, the company's management is currently working on obtaining new capital from new and existing investors. The capital raise will happen with existing and new investors through the subscription of new capital shares in the company with the addition of a share premium. The subscription period has not ended at the time the annual report is submitted, but the interest in subscribe capital shares in the company looks promising. In addition, the development in the company's operations is proceeding in accordance with management's expectations, and under these conditions, the annual report is submitted under the assumption of going concern.